SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (922)3/19/1999 7:26:00 AM
From: Thure Meyer   of 1837
 
Doug,

You are starting to worry about everything and nothing.

This whole thing is out of our control so sit back and relax. I for one am encouraged at the sudden extreme volatility on a minor news item. It shows a blind hair trigger response (it looks like people bought just on the basis of an announcement without even reading what it was) and if the FDA announces Cenestin then I expect a huge upward surge.

Its difficult to wait when Christmas seems right around the corner but just hasn't quite arrived. Just remember the fundamentals, i.e., the outstanding shares are around 20,000,000, the conjugated estrogen market is 1+ billion. Just 10% of that adds over $5 per share in gross revenue and at todays P/E's that translates into a big stock price.

So, chill and cross your fingers.

Thure
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News